J&T Global Express: Game changer or just a rabble rouser?
The logistics provider has filed for a Hong Kong IPO, aiming to become one of China’s top three delivery companies Key Takeaways: J&T Global Express has lost money for the…
HBM rises from the ashes as a research partner for drug giants
The cash-strapped company disposed of a factory and an advanced drug pipeline to stay in business, and is now re-positioning itself as a supplier of biomedical services Key Takeaways: HBM…
Biocytogen Unleashes Legions of High-Tech Mice to Lure IPO Investors
The major provider of gene-edited lab rodents gets the nod for a Hong Kong listing after abandoning a plan to float shares on Shanghai’s STAR Market Key Takeaways: Gene-edited lab…
RELATED ARTICLES
-
Growing profits, shrinking market share test ZTO’s strategy
2507.HK ZTO.US -
JD Logistics buys out partner in its race to time-sensitive deliveries
2618.HK
-
NEWS WRAP: J&T Express sets ‘Double 11’ shipment milestone as share buyback launches
1519.HK
-
ZTO fights for market share as parcel pace slows
2057.HK ZTO.US
-
Can Kanzhun keep up its game in critical year for employment in China?
2076.HK BZ.US
- Yunji rides robotics wave to Hong Kong IPO with A-list of backers
-
Rebounding RLX plots course beyond China
RLX.US
